![Dietmar Berger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dietmar Berger
Teknisk/Vetenskaplig/F&U Direktör på
GILEAD SCIENCES, INC.
Förmögenhet: 2 M $ per 2026-06-30
Profil
Dr. Dietmar P.
Berger is a Chief Medical Officer at Gilead Sciences, Inc. and a Professor-Medicine at University of Freiburg.
He is on the Board of Directors at Arcus Biosciences, Inc. Dr. Berger was previously employed as a President by Sanofi AATD, Inc., a Chief Medical Officer & Global Head-Development by Sanofi, a Global Head-Research & Development by Atara Biotherapeutics, Inc., a Vice President-Clinical Hematology & Oncology by Genentech, Inc., a Head-Clinical Research Centre by The Scripps Research Institute, and a Head-Clinical Research Centre by Universitätsklinikum Freiburg.
He received his graduate degree from the University of Freiburg and a doctorate degree from the University of Freiburg.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-10 | 19 252 ( 0 % ) | 2 M $ | 2026-06-30 |
Senaste nyheterna om Dietmar Berger
Aktiva positioner av Dietmar Berger
| Företag | Position | Start |
|---|---|---|
| GILEAD SCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-01-02 |
| ARCUS BIOSCIENCES, INC. | Direktör/Styrelseledamot | 2025-02-06 |
University of Freiburg
 University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Tidigare kända positioner av Dietmar Berger
| Företag | Position | Slut |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2019-05-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | 2018-05-01 |
| INHIBRX, INC. | President | - |
| SANOFI | Teknisk/Vetenskaplig/F&U Direktör | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Dietmar Bergers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
68
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Freiburg
University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universitätsklinikum Freiburg
 Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Operates as a teaching hospital | Health Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
